Predictive value of brain perfusion SPECT for ketamine response in hyperalgesic fibromyalgia

Guedj, Eric; Cammilleri, Serge; Colavolpe, Cecile; Taieb, David; Laforte, Catherine; Niboyet, Jean; Mundler, Olivier
August 2007
European Journal of Nuclear Medicine & Molecular Imaging;Aug2007, Vol. 34 Issue 8, p1274
Academic Journal
Ketamine has been used successfully in various proportions of fibromyalgia (FM) patients. However, the response to this specific treatment remains largely unpredictable. We evaluated brain SPECT perfusion before treatment with ketamine, using voxel-based analysis. The objective was to determine the predictive value of brain SPECT for ketamine response. Seventeen women with FM (48 ± 11 years; ACR criteria) were enrolled in the study. Brain SPECT was performed before any change was made in therapy in the pain care unit. We considered that a patient was a good responder to ketamine if the VAS score for pain decreased by at least 50% after treatment. A voxel-by-voxel group analysis was performed using SPM2, in comparison to a group of ten healthy women matched for age. The VAS score for pain was 81.8 ± 4.2 before ketamine and 31.8 ± 27.1 after ketamine. Eleven patients were considered “good responders” to ketamine. Responder and non-responder subgroups were similar in terms of pain intensity before ketamine. In comparison to responding patients and healthy subjects, non-responding patients exhibited a significant reduction in bilateral perfusion of the medial frontal gyrus. This cluster of hypoperfusion was highly predictive of non-response to ketamine (positive predictive value 100%, negative predictive value 91%). Brain perfusion SPECT may predict response to ketamine in hyperalgesic FM patients.


Related Articles

  • Pain relievers: Painful choice?  // Consumer Reports on Health;May99, Vol. 11 Issue 5, p6 

    Focuses on pain relievers. Celecoxib; Ibuprofen; Acetaminophen; Aspirin; Ketoprofen; Naproxen; Complications from analgesics.

  • PAIN KILLER. Wickelgren, Ingrid // Current Science;4/8/2005, Vol. 90 Issue 14, p10 

    Focuses on the dangerous effects of analgesic drugs.

  • Salve the Day. Draper, David // Field & Stream;Nov2010, Vol. 115 Issue 7, p42 

    The article offers information on pain reliever, Big Balm.

  • Functional Neuroimaging in the Examination of Effects of Prenatal Alcohol Exposure. Coles, Claire D.; Zhihao Li // Neuropsychology Review;Jun2011, Vol. 21 Issue 2, p119 

    Functional neuroimaging offers the opportunity to understand the effect of prenatal alcohol exposure on the activities of the brain as well as providing a window into the relationship between neural activation and the behavioral outcomes that have been described in affected individuals. Several...

  • IBZM tool: a fully automated expert system for the evaluation of IBZM SPECT studies. Buchert, Ralph; Berding, Georg; Wilke, Florian; Martin, Brigitte; Borczyskowski, Daniel; Mester, Janos; Brenner, Winfried; Clausen, Malte // European Journal of Nuclear Medicine & Molecular Imaging;Sep2006, Vol. 33 Issue 9, p1073 

    Purpose: Visual reading of [123I]IBZM SPECT scans depends on the experience of the interpreter. Therefore, semi-quantification of striatal IBZM uptake is commonly considered mandatory. However, semi-quantification is time consuming and prone to error, particularly if the volumes of interest...

  • Radiosynthesis, In Vivo Biological Evaluation, and Imaging of Brain Lesions with [123I]-CLINME, a New SPECT Tracer for the Translocator Protein. Mattner, F.; Quinlivan, M.; Greguric, I.; Pham, T.; Liu, X.; Jackson, T.; Berghofer, P.; Fookes, C. J. R.; Dikic, B.; Gregoire, M.-C.; Dolle, F.; Katsifis, A. // Disease Markers;6/25/2015, p1 

    The high affinity translocator protein (TSPO) ligand 6-chloro-2-(4′-iodophenyl)-3-(N,N-methylethyl)imidazo[1,2-a]pyridine-3-acetamide (CLINME) was radiolabelled with iodine-123 and assessed for its sensitivity for the TSPO in rodents. Moreover neuroinflammatory changes on a unilateral...

  • Dopamine transporter imaging and the effects of deep brain stimulation in patients with Parkinson’s disease. Lokkegaard, A.; Werdelin, L. M.; Regeur, L.; Karlsborg, M.; Jensen, S. R.; Brødsgaard, E.; Madsen, F. F.; Lonsdale, M. N.; Friberg, L. // European Journal of Nuclear Medicine & Molecular Imaging;Apr2007, Vol. 34 Issue 4, p508 

    Single-photon emission computed tomography (SPECT) with [123I]FP-CIT is a marker for loss of presynaptic dopamine transporters in the striatum in Parkinson’s disease (PD). We used [123I]FP-CIT SPECT in order to evaluate binding to the dopamine transporter before and after neurosurgical...

  • Hemimegalencephaly: A rare cause of hemihypoperfusion on 99m technetium-ethyl cysteinate dimer brain perfusion single-photon emission computed tomography. Damle, Nishikant A.; Singhal, Abhinav; Mukherjee, Anirban; Sahoo, Manas Kumar; Tripathi, Madhavi; Bal, Chandrasekhar // Indian Journal of Nuclear Medicine;Apr2013, Vol. 28 Issue 2, p93 

    Hemimegalencephaly is a rare congenital neuronal migration disorder that can presents with the equally rare finding of hemihypoperfusion on brain perfusion single-photon emission computed tomography (SPECT). It is an extremely rare cause of intractable epilepsy. Technetium-99m ethyl cysteinate...

  • Brain hypoperfusion on Tc-99m-ethylene dicysteine diethyl ester single-photon emission computed tomography in Hashimoto's encephalopathy. Domínguez Grande, María Luz; Constantino, Ana; Rayo, Juan Ignacio; Serrano, Justo; Infante, Jose Rafael; Garcia, Lucia; Duran, Carmen // Indian Journal of Nuclear Medicine;Apr2013, Vol. 28 Issue 2, p102 

    We present a 17-year-old female, previously diagnosed of autoimmune hyperthyroidism who had an acute neurological episode and presented high antithyroid antibodies titers, cerebral spinal fluid and electroencephalogram changes. Tc-99m ethylene dicysteine diethyl ester brain single-photon...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics